Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company’s targeted, broad-spectrum products and research programs are designed to affect key biological processes that are central to cancer. ArQule’s lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy(R) (ACT). The Cancer Survival Protein modulation platform has generated a clinical-stage product designed to inhibit a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and ( www.arqule.com )
ArQule , Inc.
19 Presidential Way
Woburn, Massachusetts 01801-5140
USA
Tel: (781) 994-0300
Fax: (781) 376-6019